Identifying and Managing Spasticity in Neurological Shoulder Dysfunction
Objective: To understand this discrepancy between diagnosis and treatment of spasticity in neurological shoulder dysfunction, we formed an expert panel to establish consensus and provide…Effectiveness of abobotulinumtoxinA in adults with lower limb spasticity: Results from the AboLiSh real world observational study
Objective: Assess longitudinal goal attainment with repeated injections of abobotulinumtoxinA (aboBoNT-A) in the lower-limb over 16-months in a routine clinical setting. Background: While the efficacy…Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real world practice
Objective: Describe abobotulinumtoxinA (aboBoNT-A) dosing parameters for the most currently targeted muscles in the routine management of lower limb spasticity. Background: The efficacy and safety…Feasibility and Comprehensibility of the SMD Decision Tree for Early Recognition of Spasticity
Objective: The comprehensibility, feasibility, and appraisal of the Spastic Movement Disorders Decision Tree (SMD-DT) was assessed by qualitative analysis of study feedback collected from raters…Social Media Listening Study to Understand the Journey and Unmet Needs of Patients Living With PSS
Objective: To employ social media listening to uncover insights into poststroke spasticity (PSS) patient experiences, unmet needs, and impact on quality of life. Background: PSS…Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study
Objective: To evaluate goal attainment and ambulation in a subpopulation of TOWER study patients treated with UK licensed doses of incobotulinumtoxinA (incoA) for injection cycles…Moderate-to-severe upper limb spasticity patterns in the elderly are improved following treatment with incobotulinumtoxinA: a pooled analysis
Objective: To compare upper limb spasticity (ULS) severity changes from baseline in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA (incoA)…Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis
Objective: To compare changes from baseline in upper limb spasticity (ULS) severity in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA…Putting the patient’s voice at the venter: Tracking the impact of botulinum neurotoxin therapy for movement disorders using patient-reported outcomes
Objective: To investigate how patient reported outcomes (PROs) perform to document the effects of a botulinum neurotoxin (BONT) treatment of movement disorders in the clinical…Quantitative gait analysis to evaluate changes in gait pattern after Botulinum toxin A injection by hemiparesis
Objective: This retrospective study aimed to assess the effect of Botulinum toxin A (BoNT-A) injections in the lower limbs of hemiparetic patients on gait parameters,…
- 1
- 2
- 3
- …
- 7
- Next Page »